1.
83例患者总的生存曲线（A）和GP组与GC组的生存期比较（B）
The survival curve of all 83 patients(A)and the comparison of overall survival(OS)in GC and GP groups(B) GP: gemcitabine+cisplatin; GC: gemcitabine+carboplatin.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.